Related Experiment Video
Updated: Aug 26, 2025
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Duration of Antibiotic Therapy for Bacterial Meningitis in Young Infants: A Systematic Review
Maïté Van Hentenryck1, Alan R Schroeder2,3, Russell J McCulloh4
1Department of Pediatrics.
Insights
Current recommendations for infant bacterial meningitis antibiotic therapy duration lack strong evidence. More research is needed to determine optimal parenteral antibiotic duration and reduce associated costs and risks.
Area of Science:
- Neonatal infectious diseases
- Pediatric neurology
- Pharmacotherapy
Background:
- Parenteral antibiotic therapy duration for bacterial meningitis in young infants (<3 months) is largely based on expert consensus.
- Prolonged antibiotic courses are common, leading to significant costs and potential risks.
- The study aimed to review existing literature on antibiotic therapy duration and outcomes in this vulnerable population.
Approach:
- A comprehensive literature search was conducted across major databases (PubMed, Embase, Cochrane Library) up to May 31, 2021.
- Studies included infants <3 months with bacterial meningitis, reporting on antibiotic route, duration, and clinical outcomes.
- Thirty-two studies (1 RCT, 25 cohort, 6 case series) met the eligibility criteria.
Key Points:
- A single randomized controlled trial found no significant difference in treatment failure between 10 and 14 days of antibiotic therapy.
- One cohort study indicated that antibiotic courses longer than 21 days did not improve outcomes compared to shorter durations.
- Most included studies had limitations such as small sample sizes or lack of outcome stratification by therapy duration, precluding meta-analysis.
Conclusions:
- High-quality prospective clinical trial data are insufficient to establish optimal parenteral antibiotic duration for infant bacterial meningitis.
- There is a critical need for rigorous comparative effectiveness research to guide evidence-based treatment guidelines.
- Optimizing antibiotic duration is crucial to balance treatment efficacy with minimizing healthcare costs and patient risks.
Background And Objectives:
Recommendations for parenteral antibiotic therapy duration in bacterial meningitis in young infants are based predominantly on expert consensus. Prolonged durations are generally provided for proven and suspected meningitis and are associated with considerable costs and risks. The objective of the study was to review the literature on the duration of parenteral antibiotic therapy and outcomes of bacterial meningitis in infants <3 months old.
Methods:
We searched PubMed, Embase, and the Cochrane Library for publications until May 31, 2021. Eligible studies were published in English and included infants <3 months old with bacterial meningitis for which the route and duration of antibiotic therapy and data on at least 1 outcome (relapse rates, mortality, adverse events, duration of hospitalization, or neurologic sequelae) were reported.
Results:
Thirty-two studies were included: 1 randomized controlled trial, 25 cohort studies, and 6 case series. The randomized controlled trial found no difference in treatment failure rates between 10 and 14 days of therapy. One cohort study concluded that antibiotic courses >21 days were not associated with improved outcomes as compared with shorter courses. The remaining studies had small sample sizes and/or did not stratify outcomes by therapy duration. Meta-analysis was not possible because of the heterogeneity of the treatments and reported outcomes.
Conclusions:
Rigorous, prospective clinical trial data are lacking to determine the optimal parenteral antibiotic duration in bacterial meningitis in young infants. Given the associated costs and risks, there is a pressing need for high-quality comparative effectiveness research to further study this question.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:26Tonsillitis II: Management
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents